¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse interstitial fibrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • submucous fibrosis
    Á¡¸·¹Ø¼¶À¯Áõ
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • degenerative diffuse cerebral sclerosis
    ÅðÇ౤¹üÀ§´ë³ú°æÈ­(Áõ)
  • diffuse
    ±¤¹üÀ§-, È®»ê-, ¹Ì¸¸-
  • diffuse aneurysm
    ±¤¹üÀ§µ¿¸ÆÀÚ·ç, ±¤¹üÀ§µ¿¸Æ·ù
  • diffuse arteriosclerosis
    ±¤¹üÀ§µ¿¸Æ°æÈ­(Áõ)
  • diffuse atelectasis
    ±¤¹üÀ§¹«±âÆó
  • diffuse cerebral sclerosis
    ±¤¹üÀ§´ë³ú°æÈ­Áõ
  • diffuse cutaneous mastocytosis
    ±¤¹üÀ§ÇǺκñ¸¸¼¼Æ÷Áõ
  • diffuse esophageal spasm
    ±¤¹üÀ§½Äµµ¿¬Ãà
  • diffuse goiter
    ±¤¹üÀ§°©»ó»ùÁ¾
  • diffuse inflammation
    ±¤¹üÀ§¿°Áõ
  • diffuse intravascular coagulation
    ±¤¹üÀ§Ç÷°ü³»ÀÀ°í
  • diffuse large B-cell lymphoma
    ±¤¹üÀ§Å«B¼¼Æ÷¸²ÇÁÁ¾
  • diffuse Lewy body disease
    ±¤¹üÀ§·¹ºñ¼Òüº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse arteriosclerosis
    ±¤¹üÀ§µ¿¸Æ°æÈ­Áõ
  • diffuse atelectasis
    ±¤¹üÀ§¹«±âÆó
  • diffuse intravascular coagulation
    ¹Ì¸¸Ç÷°ü³»ÀÀ°í
  • diffuse
    ±¤¹üÀ§-, È®»ê-, ¹Ì¸¸-
  • degenerative diffuse cerebral sclerosis
    ÅðÇ౤¹üÀ§³ú°æÈ­(Áõ)
  • diffuse erythema
    ±¤¹üÀ§È«¹Ý
  • diffuse goiter
    ¹Ì¸¸°©»ó»ùÁ¾, ±¤¹üÀ§¹æÆÐ»ùÁ¾
  • diffuse inflammation
    ¹Ì¸¸¿°Áõ
  • diffuse placenta
    ÆÛÁøÅ¹Ý
  • diffuse reflection
    ¹Ì¸¸¼º¹Ý»ç
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • diffuse sclerosis
    ±¤¹üÀ§°æÈ­Áõ
  • diffuse cerebral sclerosis
    ±¤¹üÀ§³ú°æÈ­Áõ
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertrophic interstitial neuropathy
    ºñÈļº °£Áú¼º ½Å°æº´Áõ.
  • pneumonitis,interstitial
    °£Áú¼º(Êàòõàõ)
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(¡­ãêÌèæú).
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
  • Cystic fibrosis
    ³¶¼º¼¶À¯Áõ(Òªàøàéë«ñø)
  • Fibrosis
    ¼¶À¯Áõ(àéë«ñø), ¼¶À¯È­(àéë«ûù)
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ(¡­Ù¾á¬úìηàéë«ñø).
  • hepatic fibrosis
    °£¼¶À¯Áõ(ÊÜàéë«ñø)
  • idiopathic pulmonary fibrosis
    Ư¹ß¼º Æó¼¶À¯È­Áõ(¡­øËàéë«ûùñø)
  • idiopathic systemic fibrosis
    Àü½Å¼º Ư¹ß¼º(îïãóàõ ÷åÛ¡àõ) ¼¶À¯Áõ
  • postfibrinous fibrosis
    Èļ¶À¯¼Ò¼º ¼¶À¯Áõ(ý­àéë«áÈàõ àéë«ñø)
  • preretinal fibrosis
    ¸Á¸·¾Õ¼¶À¯Áõ
  • preretinal macular fibrosis
    ¸Á¸·¾ÕȲ¹Ý¼¶À¯Áõ
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cystic fibrosis of pancreas
    ÃéÀå³¶¼º¼¶À¯Áõ(õýíôÒ¥àõàéë«ñø).
  • endocardial fibrosis
    ½É³»¸·¼¶À¯Áõ.
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ.
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ(ãýҮدãýÐÉàéë«ñø)
  • fibrosis
    ¼¶À¯È­
  • fibrosis syndrome
    ¼¶À¯ÁõÁõÈıº
  • fibrosis,endomyocardial
    ½É³»¸· ±ÙÃþ¼º
  • fibrosis,nodular subepidermal
    °áÀý¼º Ç¥ÇÇÇÏ
  • fibrosis,pipe-stem
    ÆÄÀÌÇÁ °ü
  • fibrosis,pulmonary, coal workers
    Æó, 걤ºÎ
  • fibrosis<³ª>
    ¼¶À¯Áõ(àéë«ñø), ¼¶À¯È­
  • hepatic fibrosis
    °£¼¶À¯Áõ(ÊÜàéë«ñø)
  • idiopathic pulmonary fibrosis
    Ư¹ß¼º Æó¼¶À¯È­Áõ(¡­øËàéë«ûùñø)
  • idiopathic systemic fibrosis
    Àü½Å¼º Ư¹ß¼º(îïãóàõ ÷åÛ¡àõ) ¼¶À¯Áõ
  • liver,pipe-stem fibrosis
    ÆÄÀÌÇÁ°ü¾ç ¼¶À¯È­(¡­Î·åÆ àéë«ûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pancreatic cystic fibrosis
    ÃéÀå³¶¼º¼¶À¯Áõ
  • peripheral interstitial space
    ¸»Ãʰ£Áú°ø°£
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • radiation fibrosis
    ¹æ»ç¼±¼¶À¯Áõ
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ
  • reactive fibrosis
    ¹ÝÀÀ¼º¼¶À¯È­
  • retroperitoneal fibrosis
    º¹¸·Èļ¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFP chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys...
CIPF classic interstitial pneumonitis-fibrosis; clinical illness promoting factor
DILD Diffuse Interstitial Lung Disease; ¹Ì¸¸¼º °£Áú¼º ÆóÁúȯ
CDILD chronic diffuse interstitial lung disease
DIFP diffuse interstitial fibrosing pneumonitis; diisopropyl fluorophosphonate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
CFTR Cystic Fibrosis Transmembrane Conductance Regulator Gene
CFTR Cystic Fibrosis Transmembrane Regulator
CFP Cystic fibrosis protein
EMF Endomyocardial fibrosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffuse hemorrhagic syndrome
    ¹Ì¸¸¼º ÃâÇ÷¼º ÁõÈıº
  • diffuse intravascular coagulation
    ¹ü¹ß¼º Ç÷°ü³» ÀÀ°í
  • diffuse myelitis
    ¹Ì¸¸¼º ô¼ö¿°
  • diffuse panbronchiolitis
    ¹Ì¸¸¼º ¹ü¼¼±â°üÁö¿°
    ÀϺ»¿¡¼­ ÈçÈ÷ Áø´ÜµÇ´Â È£Èí ¼¼±â°üÁöÀÇ Æ¯¹ß¼º ÁúȯÀÌ´Ù. ¹Ì±¹¿¡¼­´Â ¾ÆÁÖ µå¹°´Ù. ¿©ÀÚº¸´Ù ³²ÀÚ¿¡¼­ 2¹è ¸¹À¸¸ç, ¿¬·ÉÀº 20-80¼¼¿¡¼­ ¹ß»ýÇÑ´Ù. ȯÀÚÀÇ ´ë´Ù¼ö´Â ¸¸¼º ºÎºñµ¿¿°ÀÇ º´·ÂÀÌ ÀÖ´Ù. ½ÉÇÑ È£Èí°ï¶õ, ±âħ, °´´ã »ý»ê µîÀÌ Áß¿äÇÑ ÀÓ»ó Áõ»óÀÌ´Ù. ûÁøÇÏ¸é Æó¿¡¼­ ¼öÆ÷À½°ú ÅëÀ½ÀÌ µé¸®¸ç Æó ±â´É °Ë»ç¸¦ ÇÏ¸é Æó¼â¼º Æó ±â´É º¯È­¸¦ º¼ ¼ö ÀÖ´Ù. ÈäºÎ ¹æ»ç¼± »çÁø»ó Ư¡ÀûÀÎ ¹Ì¸¸¼º ¼Ò°áÀý À½¿µ°ú °úÆØÃ¢À» º¼ ¼ö ÀÖ´Ù. Áø´Ü¿¡´Â °³Èä Æó »ý°ËÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ´Ù.
  • diffuse peritonitis
    ¹Ì¸¸¼º º¹¸·¿°, ¹ü¹ß¼º º¹¸·¿°, »êÀ缺 º¹¸·¿°
    º¹¸·ÀÇ ¾î¶² ºÎÀ§¿¡¸¸ ÇÑÁ¤ÇÏÁö ¾Ê°í ³ÐÀº ¹üÀ§·Î ħ¹üÇÑ ¿°Áõ.
  • diffuse projection
    ±¤¹ü¼º Åõ»ç
  • diffuse redness
    ¹Ì¸¸¼º ¹ßÀû
  • diffuse sclerosis
    ¹ü¹ß¼º °æÈ­Áõ
  • diffuse thickening
    ¹Ì¸¸¼º ºñÈÄ
  • diffuse waxy spleen
    ¹Ì¸¸¼º ³³ ºñ
    ºñÀåÀÇ ¾Æ¹Ð·ÎÀÌµå º¯¼ºÀ¸·Î¼­ ƯÈ÷ Á¤¸Æµ¿ÀÇ ¿ÜÃþ°ú ¸Á»ó Á¶Á÷ÀÌ Ä§½ÀµÈ °Í.
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å
  • interstitial
    °£Áú, °£Áú¼ºÀÇ, Àç°³¼ºÀÇ
    Á¶Á÷ »çÀÌÀÇ °ø°£°ú °ü·ÃµÈ.
  • interstitial cell
    °£ ¼¼Æ÷
    ôÃßµ¿¹°ÀÇ Á¤¼Ò¿¡¼­ Á¤ÀÚ Çü¼º¿¡ °ü¿©ÇÏ´Â ¼¼Æ÷ »çÀÌ¿¡ ÀÖ´Â »ý½Ä¼± ¼¼Æ÷. °£»ð ¼¼Æ÷ ¶Ç´Â ¶óÀ̵ðÈ÷
  • interstitial cell
    °£Áú ¼¼Æ÷
  • interstitial cystitis
    °£Áú¼º ¹æ±¤¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
progressive massive fibrosis <radiology> Progressive massive fibrosis, silicosis (properly conglomerate nodules, not progressive massive fibrosis), coal worker's pneumoconiosis, density (conglomerate mass) in upper lobe, retracts toward hilum, leaves emphysematous change (bullae) at lung periphery
(12 Dec 1998)
pulmonary fibrosis Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure.
(12 Dec 1998)
subadventitial fibrosis Fibrosis in the outer media of arteries, usually the renal arteries of young women, where it causes segmental stenosis and hypertension; a variety of fibromuscular dysplasia.
Synonym: subadventitial fibrosis.
(05 Mar 2000)
nodular subepidermal fibrosis A slowly growing benign skin nodule consisting of poorly demarcated cellular fibrous tissue enclosing collapsed capillaries with scattered haemosiderin-pigmented and lipid macrophages. They are common, usually about 1 cm in diameter and occur in the dermis. Simple excision is always curative.
(12 Dec 1998)
Symmers' fibrosis A characteristic pipe-shaped fibrosis formed around hepatic portal veins in some cases of long-continued heavy infection with Schistosoma mansoni; thought to be induced by the presence of large numbers of schistosome eggs in the hepatic tissues.
Synonym: Symmers' clay pipestem fibrosis, Symmers' fibrosis.
(05 Mar 2000)
idiopathic pulmonary fibrosis <radiology> Aka: usual interstitial pneumonia (UIP), 5-6th decade; M:F = 1:1, clubbing of fingers (83%), lymphocytosis on lavage, increased occurence of bronchogenic CA, average survival of 4-6 years; 87% mortality CXR findings: occasional ground glass pattern in early stage of alveolitis, diffuse reticulations (60%) predominantly at bases, honeycombing, pleural effusion (4%); pleural thickening (6%), pneumothorax in 7% (late stage), progressive volume loss see: interstitial pulmonary fibrosis
(12 Dec 1998)
oral submucous fibrosis A precancerous condition of the oral mucosa and upper aerodigestive tract characteristically in a native of India.
(05 Mar 2000)
endocardial fibrosis Scarring or collaginosis of the endocardium.
Synonym: endocardial sclerosis.
(05 Mar 2000)
endomyocardial fibrosis A disease characterised by thickening of the endocardium, and frequently the inner third of the myocardium. The left ventricle is most frequently involved. Cardiomegaly and congestive heart failure may also be present.
(12 Dec 1998)
fibrosis The formation of fibrous tissue, fibroid or fibrous degeneration
(18 Nov 1997)
leptomeningeal fibrosis A fibrous reaction within the subarachnoid space; sometimes a sequel to infectious or chemical meningitis.
See: adhesive arachnoiditis.
(05 Mar 2000)
cerebral sclerosis, diffuse Diffuse progressive degeneration of the white matter of the brain, accompanied by mental deterioration, severe motor disturbances, and early death.
(12 Dec 1998)
goiter, diffuse toxic Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone.
(12 Dec 1998)
chronic diffuse sclerosing osteomyelitis A proliferative reaction of bone to a low-grade infection of the jaws; most often seen in middle-aged or older black women as extensive, often bilateral radio-opacities of the mandible and maxilla.
(05 Mar 2000)
hyperostosis, diffuse idiopathic skeletal A disease of elderly men characterised by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á